Screener
Collegium Pharmaceutical, Inc. COLL Jornay PM — Finite-Lived Intangible Assets, Net
Other product segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Collegium Pharmaceutical, Inc. in its filing.
Tagged under the XBRL concept us-gaap:FiniteLivedIntangibleAssetsNet.
The source filing: Collegium Pharmaceutical, Inc.’s 10-Q, filed August 6, 2026.
- Filed
- Aug 6, 2026, 7:34 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001628280-26-053851
| Line item | June 30, 2026 / Cost | June 30, 2026 / Accumulated Amortization | June 30, 2026 / Carrying Amount | December 31, 2025 / Cost | December 31, 2025 / Accumulated Amortization | December 31, 2025 / Carrying Amount |
|---|---|---|---|---|---|---|
| Jornay PM | $635,000 | $(152,986) | $482,014 | $635,000 | $(111,072) | $523,928 |
| Azstarys | 635,000 | (7,480) | 627,520 | — | — | — |
| Belbuca | 360,000 | (322,305) | 37,695 | 360,000 | (284,607) | 75,393 |
| Nucynta Products | 521,170 | (521,170) | — | 521,170 | (493,478) | 27,692 |
| Symproic | 70,000 | (31,145) | 38,855 | 70,000 | (27,503) | 42,497 |
| Total intangible assets | $2,221,170 | $(1,035,086) | $1,186,084 | $1,586,170 | $(916,660) | $669,510 |
Item 1. Condensed Consolidated Financial Statements (Unaudited).
FAQ
- What is Collegium Pharmaceutical, Inc.'s jornay PM — finite-lived intangible assets, net?
- Collegium Pharmaceutical, Inc. (COLL) reported jornay PM — finite-lived intangible assets, net of $482.01M in Q2 2026.
- How has Collegium Pharmaceutical, Inc.'s jornay PM — finite-lived intangible assets, net changed year-over-year?
- Collegium Pharmaceutical, Inc.'s jornay PM — finite-lived intangible assets, net decreased by 14.8% year-over-year, from $565.84M to $482.01M.
- What does jornay PM — finite-lived intangible assets, net mean?
- This metric reflects the current book value of a specific product's finite-lived intangible assets after deducting accumulated amortization. It provides insight into the remaining unamortized investment value of the product's intellectual property.
Ask your AI about Collegium Pharmaceutical, Inc.'s jornay pm — finite-lived intangible assets, net.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI
Claude